FDA Updates Information For Women Taking Yaz

FDA (Food and Drug Administration) safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone:

“The U.S. Food and Drug Administration (FDA) has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin.  Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.”

The drug labels (BeyazSafyralYasmin and Yaz) will now report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing birth control pills when compared to birth control pills containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products.

*Despite the health risks, Yaz and Yasmin remain among - Bayer HealthCare Pharmaceuticals, top selling products.  Currently there are over 13,000 Yaz and Yasmin lawsuits pending.

Birth control pills approved by the FDA that contain drospirenone:

Beyaz – Yaz – Yasmin – Zarah – Syeda – Safyral – Ocella – Loryna – Gianvi

You have the right to trust your medication is safe.  Tragically, this is not always the case.  Well versed in the product liability laws that protect consumers, our court appointed Yaz, Yasmin, Ocella and BeYaz MDL (Multi-district Litigation) attorney are here to help.  We represent you, we do not represent drug manufacturers or insurance companies. We invite you to contact The Maher Law Firm or Frank Eidson Attorney At Law today.